EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY 4.0

Evaluation of a Remote Therapeutic Monitoring Device and Integrated Care Platform in Outpatient Parenteral Antimicrobial Therapy

Emily A Siegrist iD, Mitchell Berenson iD, Justin D Dvorak, Jacob K Dozier, S Rae Wannier, Rita Wilson Dib, Brian M Scott, Nayle Ibragimova iD, Debbie Nail Meyer iD, Maria Alkozah iD, Michelle Salvaggio, Bryan P White und 4 weitere

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciag009 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Emily A Siegrist und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, OU Health, Oklahoma City, Oklahoma, USA. Hauptthemen laut MEDLINE: Ambulatory Care, Anti-Infective Agents, Drug Monitoring. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Unplanned healthcare utilization events, including hospital readmissions and emergency room visits, are common in patients receiving outpatient parenteral antimicrobial therapy (OPAT). Little is known about patient adherence to therapy in this setting. This clinical trial evaluates the impact of a remote therapeutic monitoring (RTM) device with an integrated care platform on all-cause healthcare utilization in patients on OPAT.

Methods

This prospective, open-label, nonrandomized study enrolled patients discharged on OPAT to receive the IV Ensure RTM device compared to contemporaneous controls. The primary outcome was all-cause healthcare utilization, including hospital readmission or emergency room visit, assessed at day 90 after discharge. Adherence to antimicrobial therapy was evaluated in the intervention group.

Results

A total of 81 patients were enrolled in the intervention group, with 131 patients in the control group. Both groups had similar baseline and OPAT characteristics. On multivariate Cox regression analysis, the RTM intervention was associated with a 39% reduction in all-cause healthcare utilization by day 60 (adjusted hazard ratio, 0.61 [95% confidence interval, .38–.96]; P = .03]) and a 38% reduction by day 90 (0.62 [.40–.95]; P = .03). In the intervention group, the overall adherence reached a median of 94%, and 61.7% of patients maintained adherence of >90% throughout their OPAT course.

Conclusions

An RTM device with an integrated care platform significantly reduced all-cause healthcare utilization events in patients on OPAT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ambulatory CareAnti-Infective AgentsDrug MonitoringHumansFemaleProspective StudiesMaleMiddle AgedAgedRemote Patient MonitoringOutpatientsAdultPatient ReadmissionAdherence InterventionsEmergency Room VisitsDelivery of Health Care, Integrated

Stichwörter der Autor:innen

OPATadherenceremote therapeutic monitoring

Substanzen

Anti-Infective Agents

Autor:innen und Institutionen

  • Department of Pharmacy, OU Health, Oklahoma City, Oklahoma, USA.
  • IV Ensure, Inc, Dallas, Texas, USA.
  • Hudson College of Public Health, University of Oklahoma Health Campus, Oklahoma City, Oklahoma, USA.
  • Division of Infectious Diseases, Department of Medicine, College of Medicine, University of Oklahoma Health Campus, Oklahoma City, Oklahoma, USA.
  • Department of Medicine, OU Health Edmond Medical Center, Edmond, Oklahoma, USA.

ORCID-Profile: Emily A Siegrist, Mitchell Berenson, Nayle Ibragimova, Debbie Nail Meyer, Maria Alkozah, Sharanjeet Thind, Dale W Bratzler, Joseph Sassine

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Siegrist, E. A., Berenson, M., Dvorak, J. D., Dozier, J. K., Wannier, S. R., Dib, R. W., Scott, B. M., Ibragimova, N., Meyer, D. N., Alkozah, M., Salvaggio, M., White, B. P., Siddique, B., Thind, S., Bratzler, D. W., & Sassine, J. (2026). Evaluation of a Remote Therapeutic Monitoring Device and Integrated Care Platform in Outpatient Parenteral Antimicrobial Therapy. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag009

Vancouver

Siegrist EA, Berenson M, Dvorak JD, Dozier JK, Wannier SR, Dib RW, et al. Evaluation of a Remote Therapeutic Monitoring Device and Integrated Care Platform in Outpatient Parenteral Antimicrobial Therapy. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag009

BibTeX
@article{Siegrist2026,
  author = {Siegrist, Emily A and Berenson, Mitchell and Dvorak, Justin D and Dozier, Jacob K and Wannier, S Rae and Dib, Rita Wilson and Scott, Brian M and Ibragimova, Nayle and Meyer, Debbie Nail and Alkozah, Maria and Salvaggio, Michelle and White, Bryan P and Siddique, Bushra and Thind, Sharanjeet and Bratzler, Dale W and Sassine, Joseph},
  title = {Evaluation of a Remote Therapeutic Monitoring Device and Integrated Care Platform in Outpatient Parenteral Antimicrobial Therapy},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciag009}
}
Kostenlos starten →